US shareholder suit another woe for KV Pharmaceutical
This article was originally published in Scrip
Troubled times continue at KV Pharmaceuticalwith the news that a shareholder class action lawsuit has been filed against the company. The suit, lodged on December 2nd, alleges that KV violated US securities laws by making misleading claims about the manufacture and marketing of certain generics and inflating the value of its stock between February 15th, 2008 and November 12th, 2008. The suit seeks unspecified damages.